About this episode

The episode features a discussion on hemophagocytic lymphohistiocytosis (HLH) with a panel of experts.

In this episode, Anthony and Bernie are joined by a panel of experts to discuss (and debate) everyone's favorite (or most feared) hematology topic - hemophagocytic lymphohistiocytosis (HLH)! Joining us on this spicy episode are: - Justin Kaner, MD - Madeleine Ochs, PharmD, BCOP - Catherine Johnson, PharmD, BCOP How should we manage these patients? H-Scores or HLH2004 criteria? What is the role for ruxolitinib? Emapalumab? CXCL9 levels? Grab your favorite drink and have a listen!

People in this episode

Hosts: Anthony Perissinotti, Bernard Marini

Guests: Justin Kaner, MD, Madeleine Ochs, PharmD, BCOP, Catherine Johnson, PharmD, BCOP

Topics covered

• hemophagocytic lymphohistiocytosis
• hematology
• patient management
• H-Scores
• HLH2004 criteria
• ruxolitinib
• emapalumab

Keywords

• HLH
• hemophagocytic lymphohistiocytosis
• H-Scores
• HLH2004 criteria
• ruxolitinib
• emapalumab
• CXCL9 levels

Mentioned in this episode

Books & works: hemophagocytic lymphohistiocytosis (HLH)

More episodes of WolverHeme Happy Hour

• Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology · April 13, 2026 · 1h 1m
• An Exercise in Uncertainty with Jonathan Gluck · February 10, 2026 · 46 min
• ASH Leukemia Review: the more we learn, the less we know! · December 17, 2025 · 1h 23m
• RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy · December 8, 2025 · 41 min
• MajesTEC-3 and ASH 2025: Let's get "TEC"nical · November 25, 2025 · 1h 10m
• Episode 40: Coffee and Community Hematology · October 24, 2025 · 51 min

Explore listener stats, chart rankings, contacts and more on the WolverHeme Happy Hour podcast page.